Previous studies have emphasized the role of the Th22 subset in patients with prurigo nodularis, where IL-22 enhances keratinocyte proliferation while inhibiting terminal differentiation, leading to epidermal hyperplasia and acanthosis, hallmarks of prurigo nodularis lesions [21]. This evidence concerns the gene IL22 and prurigo nodularis.